Sign in
4

Changes in Ownership

4D Molecular Therapeutics, Inc. Filed Acc 0000950170-23-070012

Options or other derivatives

  • President and COO acquired 260,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Derivatives
Kamal Fariborz President and COO 2023-12-11 Grant or award · Stock Option (Right to Buy) +260,000 260,000 D
Loading xslF345X05/ownership.xml…